Friday, August 31, 2012

FCTRY x Jason Freeny CAPSLs Series 1

FCTRY x Jason Freeny's CAPSLs Series 1 was recently released. These are keychains that are interchangeable and you can even store stuff inside. Pretty cool!
There are 12 different designs in Series 1. There are also special edition releases coming soon too. If you purchase a full set which includes all 12 of the original designs plus 3 blind boxes for $99 HERE, you will also get a free Limited Edition Medicine Man which is limited to 300pcs. You can't buy this one separately.
You can purchase Series 1 separately for $7.99 each except for Medicine Man.

CAPSLs (series one) include:
• 3 Eyed Squid
• 40 Watt
• Bones & Band-Aids
• Brain Monster
• Daily Dose
• Flower Bomb
• Frog Squid
• Happy Pill
• Frog Squid
• Peace Bomb
• Shark Bomb
• Spray Bomb
• Squid Monster
• Medicine Man (limited edition 300 available)

Does the name Jason Freeny sound familiar to you? Some of his custom dissected figures sold for upwards of $10,000.
In 2011, Freeny’s "Pop Anatomy" sculptures gave us a very literal look inside of  pop culture icons as Super Mario and Hello Kitty and launched Freeny into the spotlight with glowing write-ups in Gizmodo and High Snobiety, among others. With those pieces, Freeny started with mass produced toys and turned them into unique works of art. Now this web phenom is partnering with FCTRY, an independent product design firm, to turn the tables and mass producing his original creations for everyone to enjoy. For the first time, Freeny’s thousands of fans can each take home a piece of the rising star’s work.

About FCTRY/Jailbreak Collective:
Based in Brooklyn, FCTRY is an independent product design company specializing in creative applications of mass production. We dream up, design, manufacture, distribute and promote iconic offbeat products. We also work with well-known artists, developing original creations for mass audiences. Our currently available lines include the Little Giants, the Obama Action Figure, the Like & Dislike Stamp, GummyGoods and more.

No comments:

Post a Comment